(Press-News.org) An international study has revealed strong associations between oral health and survival among people diagnosed with head and neck cancer. Specifically, better oral health, as evidenced by the number of natural teeth and dental visits prior to the time of diagnosis, was associated with increased survival. Importantly, those who had more frequent dental visits were more likely to have their cancer diagnosed at an earlier, and less deadly, stage of the disease than those who had few or no dental visits.
The study, by researchers at UNC Lineberger Comprehensive Cancer Center and UNC Adams School of Dentistry, Chapel Hill, North Carolina, and Moffitt Cancer Center, Tampa, Florida, in partnership with the International Head and Neck Cancer Epidemiology (INHANCE) consortium, appeared Sept. 19, 2023, in the Journal of the National Cancer Institute.
“The INHANCE consortium’s patient data allowed us to be as thorough as possible and identify robust associations between oral health and survival,” said lead author Jason Tasoulas M.D., DMD, a current Ph.D. candidate. “We assembled a diverse and experienced team to examine records of approximately 2,500 patients from eight countries to carry out our state-of-the-art statistical analyses.”
Head and neck cancer patients were asked to self-report aspects of their oral health and hygiene, including gum bleeding, tooth brushing frequency and mouthwash use, as well as the number of natural teeth and frequency of dental visits they had during a 10-year period prior to their cancer diagnosis.
Those who had frequent dental visits (more than five visits in a reported decade) had higher overall survival at five and 10 years (74% and 60%, respectively) compared to those with no dental visits (54% at five years and 32% at 10 years). This finding was most pronounced among people with cancers of the oropharynx, which consists of the structures in the back of the throat, including the base of the tongue, tonsils and soft palate. Having no natural remaining teeth was associated with a 15% lower five-year overall survival compared to those with more than 20 natural teeth. Survival differences of less than 5%, which were not significant, were found for patient-reported gum bleeding, tooth brushing and mouthwash use.
While survival has improved during the past decades due to treatment advances, head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and accounts for about 4% of all cancers in the United States. In 2023, an estimated 66,920 people will be diagnosed with the disease in the U.S. The main environmental risk factor for the disease is tobacco use but alcohol consumption and testing positive for the human papillomavirus also increase a person’s risk for the disease.
“This current research effort capitalizes on previous data collection efforts by our team in North Carolina through the Carolina Head and Neck Cancer Epidemiology (CHANCE) study to investigate the role of oral health in patients with head and neck squamous cell carcinoma. The present report is based on a larger-scale study, accounting for geographic variability and capturing more oral health variables,” said Kimon Divaris, DDS, Ph.D., study author and James Bawden Distinguished Professor at the UNC Adams School of Dentistry and UNC Gillings School of Global Public Health.
“Inspired by Dr. Divaris’ previous work, we sought out opportunities to collaborate with a larger network of epidemiologists, surgeons, physicians, dentists and scientists from all over the world to address an important but often overlooked problem for patients with head and neck squamous cell carcinoma,” said corresponding author Antonio L. Amelio, Ph.D., vice chair of research in the Head and Neck Oncology Department and associate member of the Tumor Biology Department at Moffitt Cancer Center, and an adjunct associate professor at the UNC Department of Otolaryngology-Head and Neck Surgery. “Our hope is that these findings become a standard part of guidelines implemented for the prevention and management of head and neck squamous cell carcinomas in the near future.”
Carole Fakhry, M.D., MPH, the Charles W. Cummings M.D. Professor of Otolaryngology at Johns Hopkins School of Medicine, who was not involved in the research, called the findings significant. “This is an important study that highlights the interplay between oral health and head and neck squamous cell carcinoma and overall survival. While we seek biomarkers to predict which patient will do well, this study points out features of a history and examination that are associated with survival. Additionally, this may lead us down the road of prevention of these cancers.”
Authors and disclosures
In addition to Tasoulas, Divaris and Amelio, the article’s other authors from UNC include Siddharth Sheth DO, MPH, Wendell G. Yarbrough M.D., MMHC, and Trevor Hackman M.D., UNC Lineberger and UNC School of Medicine; Douglas R. Farquhar M.D., MPH, and Chris B. Agala Ph.D., UNC School of Medicine; and Andrew F. Olshan Ph.D., UNC Lineberger and UNC Gillings. A complete listing of authors is available in the paper published online.
Amelio is a global advisory board member and paid consultant for the LG Chem Life Sciences Innovation Center. Sheth receives honoraria from Naveris, Medscape; Speakers' Bureau: Exelixis; research funding from AstraZeneca/MedImmune, Merck, Inovio Pharmaceuticals; Exelixis and Regeneron. Yarbrough is a consultant for Olympus Medical Systems. All other authors declare no potential conflicts of interest.
The study was funded by:
The INHANCE Consortium was supported by NIH grants NCI R03CA113157 and NIDCR R03DE016611.
Studies participating in the pooled analysis were supported in the following locations:
Latin America: Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) Argentina, IMIM (Barcelona), Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP) (No. 01/01768-2), and European Commission (IC18-CT97-0222).
North Carolina (1994–1997): NIH (R01CA061188), and in part by a grant from the National Institute of Environmental Health Sciences (P30ES010126).
Central Europe: World Cancer Research Fund and the European Commission INCO-COPERNICUS Program (Contract No. IC15-CT98-0332).
The Sao Paulo & Sao Paulo2 studies were supported by the Sao Paulo Research Foundation – FAPESP (GENCAPO 04/12054-9, 10/51168-0.
Western Europe study: Supported by European Community (5th Framework Programme, grant QLK1-CT-2001-00182).
The HN5000 study was funded by the National Institute for Health Research (NIHR) grant RP-PG-0707-10034). Support was also provided, in part, by the NCI Center Core Support Grant 5P30CA016080-42 to the UNC Lineberger Comprehensive Cancer Center, University Cancer Research Fund, a UNC Lineberger Tier 3 Developmental Award, and NIH/NIDCR R01DE030123, and by monies from the State of Florida to Moffitt Cancer Cente
END
Poor oral health could lessen survival from head and neck cancer
2023-09-19
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Interventions for physical capacity and quality of life in adults with post–COVID-19 condition
2023-09-19
About The Study: The findings of this systematic review and meta-analysis suggest that rehabilitation interventions in adults with post–COVID-19 condition are associated with improvements in functional exercise capacity, dyspnea, and quality of life, with a high probability of improvement compared with the current standard care. The certainty of evidence was moderate for functional exercise capacity and quality of life and low for other outcomes.
Authors: Dimitra V. Pouliopoulou, M.Sc., of Western University in London, Ontario, Canada, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link ...
Premenstrual disorders, timing of menopause, and severity of vasomotor symptoms
2023-09-19
About The Study: In this study of 3,635 female participants in the U.S., premenstrual disorders (PMDs) were associated with increased risks of early menopause and moderate or severe vasomotor symptoms (VMS). PMDs may be indicative of underlying physiology linked to early menopause and VMS, suggesting a phenotype observable during the reproductive years that may allow clinicians to target women at risk of earlier menopause and subsequent health risks later in the life course.
Authors: Yihui Yang, M.P.H., and Donghao Lu, M.D., Ph.D., of the Karolinska Institutet in Stockholm, Sweden are the corresponding authors.
To ...
Study finds two antibiotics for children with sinusitis equally effective, but one had fewer side effects
2023-09-19
Brigham researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin
Acute sinusitis is one of the most common causes for children to be put on antibiotic medications, with patients in the United States filing nearly 5 million antibiotic prescriptions every year to treat the condition. The drugs amoxicillin and amoxicillin-clavulanate make up most of those prescriptions, but there is a lack of consensus on which should be first-line ...
Women given new insight into blood clot risk
2023-09-19
New research from Queen Mary University of London, published in iScience, shows an increased risk of blood clots in women who have any combination of a particular gene mutation, oestrogen use, or common medical conditions – specifically: obesity, high blood pressure, high cholesterol, and kidney disease.
Women with the Factor V Leiden (FVL) gene mutation who had been prescribed oestrogen had more than double the risk of blood clotting compared to women who did not have this mutation. And almost 20% of the women who carry FVL, ...
A mysterious blue molecule will help make better use of light energy
2023-09-19
Researchers at IOCB Prague are the first to describe the causes of the behavior of one of the fundamental aromatic molecules, which fascinates the scientific world not only with its blue color but also with other unusual properties – azulene. Their current undertaking will influence the foundations of organic chemistry in the years to come and in practice will help harness the maximum potential of captured light energy. The article appeared in the Journal of the American Chemical Society (JACS).
Azulene has piqued the ...
New research unveils pseudomonas cyclic lipopeptide medpeptin’s role in modulating plant immunity
2023-09-19
A groundbreaking research study conducted by Hai-Lei Wei's research team at the Chinese Academy of Agricultural Sciences in China has revealed significant insights into the biosynthesis and modulation of plant immunity by a novel cyclic lipopeptide called medpeptin, produced by Pseudomonas mediterranea. The findings, published in Engineering, shed light on the intricate structure–function interactions of cyclic lipopeptides (CLPs) and open new avenues for the development of plant disease resistance strategies.
CLPs, multifunctional secondary metabolites produced by various bacteria, have emerged as key elicitors of plant ...
The MIT Press announces the Open Encyclopedia of Cognitive Science, a paradigm shift in open access reference works
2023-09-19
For over a generation, the MIT Encyclopedia of the Cognitive Sciences has been an essential resource for researchers and students of cognitive science and neuroscience. Today, the MIT Press proudly announces its intellectual successor—the Open Encyclopedia of Cognitive Science (OECS), a dynamic and openly accessible web reference poised to guide the next generation of exploration. Thanks to generous funding from James S. McDonnell Foundation and the Allen Institute for AI, the first set of articles will be published in 2024.
In ...
Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients
2023-09-19
HOUSTON ― Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system's ability to detect and remove potentially harmful cells, according to researchers at
The University of Texas MD Anderson Cancer Center.
The findings, published today in Clinical Cancer Research, revealed that LS carriers participating in a high-intensity training (HIIT) regimen saw a reduction of the inflammatory marker prostaglandin E2 (PGE2) in both the colon and the blood. Researchers ...
COVID-infected adults with 4 or more underlying diseases or advanced age, face higher risk of ICU stay, death
2023-09-19
Whether vaccinated or not, having at least four disease risk factors put adults hospitalized due to COVID-19 at higher risk for critical outcomes, according to a 10-state study from the Centers for Disease Control and Prevention’s (CDC’s) VISION Network. The study describes the characteristics of adults hospitalized with COVID-19 from June 2021 through March 2023 and enumerates their risk factors for critical outcomes, defined as intensive care unit (ICU) admission and/or in-hospital death.
It ...
Novel ligands for transition-metal catalysis of photoreactions
2023-09-19
Transition metals form catalytic complexes that can speed up various chemical processes, especially in the production of pharmaceuticals as well as various pigments, dyes, and laboratory reagents like sulfuric acid. The use of light emitting diodes (LEDs) has boosted the use of visible light in reaction catalysis, and scientists have developed photo-redox catalysts made of iridium and ruthenium, which facilitate catalysis when irradiated with specific wavelengths of light. Further, scientists have even demonstrated visible light photoreactions with palladium complexes without the use of photo-redox catalysts. While several such transition metal-catalyzed ...